For the Quarter Ending June 2026
Atenolol Prices in APAC
- In China, the Atenolol Price Index rose quarter-over-quarter in Q2 2026, driven by increasing producer input costs. The average prices of Atenolol FOB India settled at price USD 17100/MT in June quarter 2026.
- Atenolol production costs increased in Q2 2026, influenced by a 4.1% rise in PPI in June 2026.
- Demand for Atenolol faced headwinds in May 2026 as retail sales fell 0.6% and consumer confidence declined.
- The Manufacturing Index expanded in June 2026, supporting stable pharmaceutical manufacturing and supply chains.
- Epichlorohydrin prices, a key feedstock for Atenolol, declined in June 2026 due to supply-demand imbalance.
- China's industrial production grew 4.5% in May 2026, indicating a robust base for Atenolol manufacturing.
- Consumer purchasing power for essential drugs was preserved by a 1.0% CPI increase and 5.0% unemployment in June 2026.
Why did the price of Atenolol change in June 2026 in APAC?
- Producer Price Index rose 4.1% in June 2026, increasing Atenolol manufacturing input costs.
- Electricity prices for energy-intensive sectors in China rose in June 2026, impacting production.
- Epichlorohydrin feedstock prices declined in June 2026 due to supply-demand imbalance.
Atenolol Prices in North America
- In the United States, the Atenolol Price Index rose quarter-over-quarter in Q2 2026, driven by robust consumer spending and elevated production costs.
- Atenolol production costs increased in Q2 2026, as the Producer Price Index rose 6.5% year-over-year in May 2026.
- Propylene feedstock costs surged in Q1 2026, influencing Atenolol production expenses into Q2 due to shortages.
- Atenolol demand remained strong in Q2 2026, supported by a 6.9% year-over-year rise in retail sales in May 2026.
- Consumer Price Index rose 4.2% year-over-year in May 2026, indicating inflationary pressures affecting healthcare affordability.
- US acetone supply tightened in April and May 2026 due to operational challenges, but became abundant by June 2026.
- Export-driven propane demand in Q1 2026 tightened domestic propylene supply, impacting Atenolol production in Q2.
- Biopharma executives' confidence strengthened significantly during Q2 2026, supporting market stability and investment.
Why did the price of Atenolol change in June 2026 in North America?
- Producer Price Index rose 6.5% in May 2026, increasing raw material and manufacturing costs.
- Strong retail sales (6.9% in May 2026) and low unemployment (4.2% in June 2026) bolstered demand.
- Propylene feedstock costs surged in Q1 2026, contributing to higher production expenses.
Atenolol Prices in Europe
- In Germany, the Atenolol Price Index rose quarter-over-quarter in Q2 2026, driven by significant increases in production costs.
- Atenolol production costs faced mounting pressure in Q2 2026 from rising raw material and transportation expenses.
- Producer prices increased by 2.2% year-over-year in May 2026, directly raising Atenolol chemical precursor costs.
- The Consumer Price Index rose 2.3% year-over-year in June 2026, indicating inflationary pressures on Atenolol manufacturing.
- Atenolol demand outlook was mixed; retail sales declined 0.3% year-over-year in April 2026, impacting affordability.
- Industrial production declined 1.20% year-over-year in April 2026, alongside a contracting Manufacturing Index in June 2026.
- Natural gas prices in Europe remained elevated into Q2 2026, increasing energy costs for Atenolol production.
- Supply chain disruptions intensified in Q2 2026 due to geopolitical events, affecting Atenolol trade flows.
- The chemical industry's business climate improved in June 2026, temporarily strengthening demand for chemical products.
Why did the price of Atenolol change in June 2026 in Europe?
- Rising producer prices, up 2.2% year-over-year in May 2026, increased Atenolol raw material and input costs.
- Elevated natural gas prices in Q2 2026 and surging electricity costs in May 2026 significantly raised production expenses.
- Improved chemical industry business climate in June 2026, alongside shifting trade flows, temporarily strengthened demand.
For the Quarter Ending March 2026
Atenolol Prices in North America
- In United States, the Atenolol Price Index rose quarter-over-quarter in Q1 2026, driven by surging propylene costs.
- The Atenolol Production Cost Trend increased in March 2026 as a 4.0% PPI rise elevated precursor expenses.
- The Atenolol Demand Outlook strengthened in March 2026, bolstered by 4.0% retail sales growth ensuring prescription fulfillment.
- A stable 4.3% unemployment rate in March 2026 sustained insurance coverage, driving steady Atenolol prescription adherence.
- Consumer confidence reached 91.8 in March 2026, encouraging routine medical check-ups and supporting robust Atenolol demand.
- Industrial production grew 0.7% in March 2026, limiting surplus intermediate supply and supporting Atenolol pricing power.
- The Manufacturing Index expanded in March 2026, ensuring steady intermediate production and reliable Atenolol availability.
- The Atenolol Price Forecast indicated upward pressure in Q1 2026 due to a 3.3% CPI increase.
Why did the price of Atenolol change in March 2026 in North America?
- Upstream propylene feedstock costs surged sequentially in Q1 2026 due to global supply chain disruptions.
- Global ammonia availability tightened significantly in Q1 2026 following planned and unplanned facility shutdowns.
- United States pharmaceutical imports faced new tariff pressures in Q1 2026, impacting active ingredient trade.
Atenolol Prices in APAC
- In China, the Atenolol Price Index rose quarter-over-quarter in Q1 2026, driven primarily by escalating upstream feedstock expenses.
- The Producer Price Index increased by 0.5% in March 2026, reflecting higher Atenolol Production Cost Trends.
- Consumer Price Index grew 1.0% in March 2026, supporting stable Atenolol Demand Outlook for cardiovascular medications.
- Industrial production expanded 5.7% year-over-year in March 2026, ensuring steady availability of intermediates for Atenolol synthesis.
- Retail sales grew slowly at 1.7% in March 2026, slightly limiting bulk pharmacy inventory stocking activities.
- The urban unemployment rate reached 5.4% in March 2026, negatively impacting branded retail pharmaceutical purchasing power.
- Production costs for key feedstock epichlorohydrin surged during Q1 2026 due to escalating upstream propylene expenses.
- Buyers initiated strategic inventory buildup in Q1 2026, anticipating an upward Atenolol Price Forecast amid constraints.
- Export dynamics shifted in February 2026 after India imposed anti-dumping duties on Chinese isopropylamine chemical imports.
Why did the price of Atenolol change in March 2026 in APAC?
- Upstream propylene supply severely constrained in Q1 2026 as dehydrogenation units operated at reduced capacities.
- Regional epichlorohydrin supply tightened during Q1 2026 due to scheduled maintenance turnarounds at chlorohydrination plants.
- Pharmaceutical sector demand strengthened in Q1 2026, driven by surging cross-border outlicensing deal value activities.
Atenolol Prices in Europe
- In Germany, the Atenolol Price Index rose quarter-over-quarter in Q1 2026, driven by surging feedstock costs.
- In March 2026, Germany's CPI rose 2.7% year-over-year, while producer prices declined slightly by 0.2%.
- The manufacturing index expanded in March 2026, despite stagnant industrial production at 0.0% in February 2026.
- Stable unemployment at 4.2% and a 0.7% retail sales increase in February 2026 supported Atenolol demand.
- Negative consumer confidence at -24.7 in March 2026 pressured branded Atenolol pricing, favoring generic alternatives.
- The Atenolol production cost trend surged in March 2026 as naphtha and propylene prices spiked.
- Raw material inventories tightened in March 2026 following early Q1 2026 surpluses and maritime route closures.
- The Atenolol demand outlook strengthened as pharmaceutical producer prices surged in Germany during February 2026.
- The Atenolol price forecast reflected upward pressure following severe Middle East trade disruptions in March 2026.
Why did the price of Atenolol change in March 2026 in Europe?
- Naphtha and propylene feedstock costs surged in Europe during March 2026 due to geopolitical tensions.
- Severe Middle East export disruptions tightened raw material availability for Atenolol precursors during March 2026.
- Strong pharmaceutical sector activity in Germany during February 2026 drove downstream demand for active ingredients.
For the Quarter Ending December 2025
Atenolol Prices in North America
- In United States, the Atenolol Price Index rose quarter-over-quarter in Q4 2025, influenced by increasing production costs.
- Atenolol production costs increased, driven by a 3.0% year-over-year rise in PPI in November 2025.
- Demand for Atenolol was indirectly supported by a 3.3% year-over-year increase in retail sales in November 2025.
- The Atenolol Price Forecast indicates continued upward pressure from input costs, balanced by broader chemical oversupply.
- US natural gas spot prices gradually rose in the final months of 2025, impacting Atenolol manufacturing expenses.
- Industrial production expanded by 2.0% year-over-year in December 2025, ensuring stable access to manufacturing resources.
- A 4.4% unemployment rate in December 2025 indirectly supported Atenolol demand by increasing healthcare access.
- Trade and tariff uncertainty remained a significant market trend for Q4 2025, affecting supply chain stability.
Why did the price of Atenolol change in December 2025 in North America?
- Production costs increased due to a 3.0% year-over-year rise in PPI in November 2025.
- Energy expenses for Atenolol manufacturing rose as US natural gas spot prices climbed in Q4 2025.
- The broader chemical industry experienced uneven demand and global oversupply during Q4 2025.
Atenolol Prices in Europe
- In Germany, the Atenolol Price Index fell in Q4 2025, driven by intensified competitive pressures from abroad in October 2025.
- Atenolol production costs declined in December 2025, as producer prices (PPI) decreased by 2.5% year-on-year.
- Demand for Atenolol remained stable in Q4 2025, supported by demographic tailwinds, including an aging population.
- The Manufacturing Index showed a contracting trend in December 2025, indicating a weaker economic environment for the chemical sector.
- Industrial production in Germany increased by 0.8% year-on-year in October 2025, supporting a stable manufacturing backdrop.
- Elevated raw material costs challenged Germany's chemical industry throughout Q4 2025, despite CPI rising 1.8% year-on-year in December 2025.
- European gas stockpiles tightened by December 2025, reflecting a less comfortable energy supply situation for early winter.
- The Atenolol price forecast suggests continued downward pressure from global overcapacity and a strong euro in December 2025, with consumer confidence at -17.5.
Why did the price of Atenolol change in December 2025 in Europe?
- Producer prices (PPI) decreased by 2.5% year-on-year in December 2025, lowering Atenolol production costs.
- Intensified competitive pressures from abroad led chemical companies to lower price plans in October 2025.
- Global overcapacity and a strong euro strained Germany's chemicals sector in December 2025.
Atenolol Prices in APAC
- In China, the Atenolol Price Index fell quarter-over-quarter in Q4 2025, influenced by declining producer prices in December 2025.
- Atenolol production costs decreased in December 2025, with Producer Price Index falling 1.9% year-over-year.
- Demand for Isopropylamine, a key Atenolol precursor, strengthened in 2025, supporting overall demand.
- China's Manufacturing Index expanded in December 2025; industrial production rose 5.2% year-over-year.
- Widespread chemical industry overcapacity and new capacities lengthened Atenolol supply throughout 2025.
- China's medicine exports, including Atenolol APIs, steadily increased during the first eleven months of 2025.
- The Consumer Price Index rose 0.8% year-over-year in December 2025, indicating stable consumer inflation.
- Retail sales grew 0.9% year-over-year in December 2025, while unemployment stood at 5.1%.
- Atenolol price forecast suggests continued downward pressure due to falling selling prices in December 2025.
Why did the price of Atenolol change in December 2025 in APAC?
- Producer Price Index declined 1.9% in December 2025, reducing Atenolol production costs.
- Widespread chemical overcapacity and new capacities lengthened Atenolol supply throughout 2025.
- Selling prices for manufactured goods continued to fall in China in December 2025, impacting market.
For the Quarter Ending September 2025
Atenolol Prices in North America
- In the United States, the Atenolol Price Index rose in Q3 2025, driven by rising production costs and constrained supply.
- Atenolol production costs increased in Q3 2025, influenced by rising PPI (2.6% in August 2025).
- Demand for Atenolol was supported by an upward pharmaceutical sector trajectory during Q3 2025.
- Phenol feedstock costs for Atenolol production experienced upward movement in North America in Q3 2025.
- US natural gas prices saw a year-over-year uptick during Q3 2025, raising Atenolol manufacturing expenses.
- Overall inventories decreased in August and September 2025, indicating tighter Atenolol market conditions.
- Strong retail sales (5.42% in September 2025) and low unemployment (4.3% in September 2025) supported healthcare spending.
- Constrained phenol supply in Q3 2025 due to turnarounds impacted Atenolol production capacity.
- Rising CPI (3.0% in September 2025) signaled higher operational costs for Atenolol manufacturers.
- Industrial production showed a slight 0.1% year-over-year growth in September 2025.
Why did the price of Atenolol change in September 2025 in North America?
- Rising PPI (2.6% in August 2025) and natural gas prices increased Atenolol production costs.
- Constrained phenol supply in Q3 2025 due to turnarounds impacted Atenolol availability.
- Strong pharmaceutical sector activity and increased drug approvals drove Atenolol demand.
Atenolol Prices in Europe
- In Germany, Atenolol Price Index rose in Q3 2025, driven by strengthening pharmaceutical demand and tightening regional supply.
- Atenolol production costs were influenced by a -1.7% PPI in September 2025 and declining propylene feedstock costs.
- Operating costs for Atenolol production increased due to a 2.4% CPI in September 2025 and elevated energy prices.
- Atenolol demand outlook strengthened in Q3 2025, supported by an aging population and low 3.9% unemployment.
- Regional supply tightened in Q3 2025 due to plant closures and a -1.0% industrial production decline.
- Chemical industry inventories, including raw materials and finished goods, shrank in Q3 2025 from accelerating destocking.
- The Manufacturing Index was contracting in September 2025, indicating a slowdown in the broader German industrial sector.
- Modest 0.8% retail sales growth in September 2025 supported the economy, despite consumer confidence at -23.6.
Why did the price of Atenolol change in September 2025 in Europe?
- Pharmaceutical demand strengthened in Q3 2025, supported by a low 3.9% unemployment rate.
- Production costs were influenced by a -1.7% PPI in September 2025 and elevated energy prices.
- Regional supply tightened due to plant closures in Q3 2025, while inventories shrank from destocking.
Atenolol Prices in APAC
- In China, the Atenolol Price Index faced downward pressure in Q3 2025, influenced by a contracting Producer Price Index (-2.3% in September 2025).
- Atenolol production costs rose during Q3 2025, driven by elevated naphtha costs in August and increasing phenol feedstock prices.
- Demand for Atenolol was supported in Q3 2025 by an aging population and an expanding non-manufacturing sector.
- Raw material inventories for manufacturing, including Atenolol inputs, tightened throughout Q3 2025, indicating supply constraints.
- China's industrial production increased by 6.5% year-on-year in September 2025, supporting a stable pharmaceutical manufacturing environment.
- Consumer confidence remained pessimistic in September 2025 (index 89.6), influencing patient willingness for medical care.
- The Manufacturing Index showed sustained contraction in Q3 2025, though with gradual improvement, affecting supply chain stability.
- Retail sales grew by 3.0% year-on-year in September 2025, supporting consumer spending and patient affordability for Atenolol.
Why did the price of Atenolol change in September 2025 in APAC?
- Producer Price Index contracted by 2.3% year-on-year in September 2025, reducing overall manufacturing costs.
- Phenol feedstock benzene prices in Northeast Asia inched up in August, elevating Atenolol production expenses.
- Consumer Price Index contracted by 0.3% year-on-year in September 2025, signaling deflationary pressure.
